These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16369385)

  • 1. "Good Publication Practice for Pharmaceutical Companies": where are we now?
    Wager E
    MedGenMed; 2005 Apr; 7(2):6. PubMed ID: 16369385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on: developing good scientific publishing practices: one pharmaceutical company's perspective.
    Norris RA
    Curr Med Res Opin; 2010 Jul; 26(7):1675-6. PubMed ID: 20450261
    [No Abstract]   [Full Text] [Related]  

  • 3. [Publication ethics: regulation of financial conflicts of interests in medical journals].
    Kakuk P
    Lege Artis Med; 2011 Jan; 21(1):65-71. PubMed ID: 21469379
    [No Abstract]   [Full Text] [Related]  

  • 4. Disclosure of conflicts of interest in biomedical publications.
    Miller DR
    Can J Anaesth; 2008 May; 55(5):265-7, 267-9. PubMed ID: 18451113
    [No Abstract]   [Full Text] [Related]  

  • 5. Competing interests.
    Sharpe VA; Gurian-Sherman D
    Nat Biotechnol; 2003 Oct; 21(10):1131. PubMed ID: 14520389
    [No Abstract]   [Full Text] [Related]  

  • 6. Nothing to see here.
    Nat Biotechnol; 2008 May; 26(5):476. PubMed ID: 18464755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research dishonesty and conflict of interest.
    Frizelle F
    N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259
    [No Abstract]   [Full Text] [Related]  

  • 8. 'Interests' in medicine and the inadequacy of disclosure.
    Kerridge I
    Aust N Z J Psychiatry; 2012 Jun; 46(6):501-3. PubMed ID: 22679203
    [No Abstract]   [Full Text] [Related]  

  • 9. In the dark: drug companies should be forced to publish all the results of clinical trials.
    Chalmers I
    New Sci; 2004 Mar 6-12; 181(2437):19. PubMed ID: 15139350
    [No Abstract]   [Full Text] [Related]  

  • 10. Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines.
    Cosgrove L; Bursztajn HJ; Krimsky S; Anaya M; Walker J
    Psychother Psychosom; 2009; 78(4):228-32. PubMed ID: 19401623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impugning the integrity of medical science: the adverse effects of industry influence.
    DeAngelis CD; Fontanarosa PB
    JAMA; 2008 Apr; 299(15):1833-5. PubMed ID: 18413880
    [No Abstract]   [Full Text] [Related]  

  • 12. Declaration of conflicts of interest in scientific publications.
    Möller HJ
    World J Biol Psychiatry; 2009; 10(1):2-5. PubMed ID: 19140091
    [No Abstract]   [Full Text] [Related]  

  • 13. Ghostbusters should only bust ghosts.
    Adamson LM; Whitman M; Jacobs A; Bunting-Early TE
    Nat Biotechnol; 2008 Oct; 26(10):1067-8. PubMed ID: 18846064
    [No Abstract]   [Full Text] [Related]  

  • 14. The corporate coauthor.
    Fugh-Berman A
    J Gen Intern Med; 2005 Jun; 20(6):546-8. PubMed ID: 15987332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conflict of interest, journal review, and publication policy.
    Klein DF; Glick ID
    Neuropsychopharmacology; 2008 Dec; 33(13):3023-6. PubMed ID: 18650804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Authorship policy.
    Novack GD
    Am J Ophthalmol; 2009 Jan; 147(1):184; author reply 184-5. PubMed ID: 19100357
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug companies and publishers set out 10 steps to enhance credibility of industry sponsored trials.
    Roehr B
    BMJ; 2012 May; 344():e3767. PubMed ID: 22641830
    [No Abstract]   [Full Text] [Related]  

  • 18. How to ensure our readers' trust: the proper attribution of authors and contributors.
    Liesegang TJ; Albert DM; Schachat AP
    Am J Ophthalmol; 2008 Sep; 146(3):337-40. PubMed ID: 18724976
    [No Abstract]   [Full Text] [Related]  

  • 19. American Society of Clinical Oncology policy for relationships with companies: background and rationale.
    American Society of Clinical Oncology
    J Clin Oncol; 2013 Jun; 31(16):2037-42. PubMed ID: 23610121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good publication practices for pharmaceutical companies: why we need another set of guidelines.
    Wager E; Field EA; Grossman L
    Curr Med Res Opin; 2003; 19(3):147-8. PubMed ID: 12814126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.